Satsuma Pharmaceuticals

With skin in the game, Satsuma's partner offers buyout to get migraine spray to market
Fierce Biotech
Mon, 04/17/23 - 12:07 pm
Satsuma Pharmaceuticals
Japan
migraines
Shin Nippon Biomedical
M&A
Satsuma peels off staff, cutting head count by 36% to save cash while searching for a deal
Fierce Biotech
Wed, 03/29/23 - 09:37 am
Satsuma Pharmaceuticals
layoffs
migraines
STS101
Satsuma in the red after 2nd phase 3 migraine flop spurs search for strategic alternatives
Fierce Biotech
Mon, 11/14/22 - 10:48 am
Satsuma Pharmaceuticals
clinical trials
migraines
STS101
intra-nasal drug delivery
Satsuma peels off fresh strip of long-term migraine study data ahead of planned FDA filing
Fierce Pharma
Mon, 09/26/22 - 10:57 am
Satsuma Pharmaceuticals
migraines
clinical trials
STS101
Satsuma Pharma's STS101 flunks late-stage migraine study, shares down 84%
Seeking Alpha
Thu, 09/10/20 - 10:23 am
migraines
Satsuma Pharmaceuticals
clinical trials
STS101
Satsuma Pharmaceuticals Files for $80 Million IPO
CP Wire
Thu, 09/12/19 - 10:25 am
Satsuma Pharmaceuticals
STS101
migraine
IPOs
Satsuma Pharmaceuticals Files for $80 Million IPO
Thu, 09/12/19 - 09:33 am
Satsuma Pharmaceuticals
STS101
migraine
IPOs
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
Xconomy
Sat, 08/17/19 - 01:28 pm
IPOs
SpringWorks Therapeutics
Pfizer
Satsuma Pharmaceuticals
Why Satsuma investors see room for another migraine therapy
BioCentury
Wed, 04/24/19 - 10:38 pm
Satsuma Pharmaceuticals
migraines
STS101
clinical trials